Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

UROFOLLITROPIN for Ovulation induction: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 37 adverse event reports in the FDA FAERS database where UROFOLLITROPIN was used for Ovulation induction.

Most Reported Side Effects for UROFOLLITROPIN

Side Effect Reports % Deaths Hosp.
Ovarian hyperstimulation syndrome 73 72.3% 1 66
Abdominal distension 25 24.8% 0 21
Abdominal pain 20 19.8% 0 16
Ascites 13 12.9% 0 13
Nausea 12 11.9% 0 11
Chest discomfort 10 9.9% 0 8
Dyspnoea 10 9.9% 0 10
Vomiting 10 9.9% 0 8
Oliguria 7 6.9% 0 7
Off label use 5 5.0% 0 4
Pelvic fluid collection 5 5.0% 0 5

Other Indications for UROFOLLITROPIN

In vitro fertilisation (26) Assisted reproductive technology (7) Product used for unknown indication (7) Infertility (6)

Other Drugs Used for Ovulation induction

CHORIOGONADOTROPIN ALFA (460) FOLLITROPIN (249) CLOMIPHENE (124) LETROZOLE (122) MENOTROPINS (107) FOLLITROPIN BETA (86) LUTROPIN ALFA (86) TRIPTORELIN (73) LEUPROLIDE (64) GONADOTROPHIN, CHORIONIC (57)

Related Pages

UROFOLLITROPIN Full Profile All Ovulation induction Drugs UROFOLLITROPIN Demographics UROFOLLITROPIN Timeline